Analysen zu Novo Nordisk
| 11.09.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 10.09.25 | Novo Nordisk Outperform | Bernstein Research | |
| 10.09.25 | Novo Nordisk Neutral | UBS AG | |
| 10.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 08.09.25 | Novo Nordisk Neutral | UBS AG | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 04.09.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 01.09.25 | Novo Nordisk Neutral | UBS AG | |
| 29.08.25 | Novo Nordisk Neutral | UBS AG | |
| 27.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 26.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 21.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 19.08.25 | Novo Nordisk Neutral | UBS AG | |
| 18.08.25 | Novo Nordisk Neutral | UBS AG | |
| 12.08.25 | Novo Nordisk Neutral | UBS AG | |
| 11.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 08.08.25 | Novo Nordisk Neutral | UBS AG | |
| 08.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 08.08.25 | Novo Nordisk Halten | DZ BANK | |
| 07.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 07.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 07.08.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 06.08.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 06.08.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.08.25 | Novo Nordisk Neutral | UBS AG | |
| 05.08.25 | Novo Nordisk Neutral | UBS AG | |
| 04.08.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 01.08.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 30.07.25 | Novo Nordisk Equal Weight | Barclays Capital | |
| 30.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 29.07.25 | Novo Nordisk Halten | DZ BANK | |
| 29.07.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 28.07.25 | Novo Nordisk Market-Perform | Bernstein Research | |
| 18.07.25 | Novo Nordisk Buy | UBS AG | |
| 18.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 16.07.25 | Novo Nordisk Buy | UBS AG | |
| 15.07.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 11.07.25 | Novo Nordisk Buy | UBS AG | |
| 09.07.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.07.25 | Novo Nordisk Buy | UBS AG | |
| 01.07.25 | Novo Nordisk Buy | UBS AG | |
| 30.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 30.06.25 | Novo Nordisk Buy | UBS AG | |
| 24.06.25 | Novo Nordisk Buy | Deutsche Bank AG | |
| 24.06.25 | Novo Nordisk Buy | UBS AG | |
| 23.06.25 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 23.06.25 | Novo Nordisk Overweight | Barclays Capital | |
| 23.06.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 20.06.25 | Novo Nordisk Buy | UBS AG |
Aktuelle Aktienanalysen
| 19.02.26 | Münchener Rückversicherungs-Gesellschaft Kaufen | DZ BANK | |
| 19.02.26 | HOCHTIEF Hold | Jefferies & Company Inc. | |
| 19.02.26 | Sixt Kaufen | DZ BANK | |
| 19.02.26 | CANCOM Kaufen | DZ BANK | |
| 19.02.26 | BMW Kaufen | DZ BANK | |
| 19.02.26 | Boeing Buy | Jefferies & Company Inc. | |
| 19.02.26 | Vonovia Kaufen | DZ BANK | |
| 19.02.26 | Walmart Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Semperit neutral | Erste Group Bank | |
| 19.02.26 | CTS Eventim Buy | Deutsche Bank AG | |
| 19.02.26 | Enel Market-Perform | Bernstein Research | |
| 19.02.26 | Ottobock Buy | Deutsche Bank AG | |
| 19.02.26 | GSK Hold | Deutsche Bank AG | |
| 19.02.26 | Airbus Buy | Deutsche Bank AG | |
| 19.02.26 | Volvo AB Hold | Deutsche Bank AG | |
| 19.02.26 | TRATON Buy | Deutsche Bank AG | |
| 19.02.26 | Daimler Truck Buy | Deutsche Bank AG | |
| 19.02.26 | Santander Buy | UBS AG | |
| 19.02.26 | Douglas Neutral | UBS AG | |
| 19.02.26 | KRONES Buy | UBS AG | |
| 19.02.26 | Nestlé Neutral | UBS AG | |
| 19.02.26 | JOST Werke Buy | Warburg Research | |
| 19.02.26 | AIR France-KLM Neutral | UBS AG | |
| 19.02.26 | Airbus Buy | UBS AG | |
| 19.02.26 | Lenzing Hold | Deutsche Bank AG | |
| 19.02.26 | Renault Sell | UBS AG | |
| 19.02.26 | STRABAG accumulate | Erste Group Bank | |
| 19.02.26 | Knorr-Bremse Buy | UBS AG | |
| 19.02.26 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 19.02.26 | freenet Sell | UBS AG | |
| 19.02.26 | AIR France-KLM Sector Perform | RBC Capital Markets | |
| 19.02.26 | Enel Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | AIR France-KLM Underweight | Barclays Capital | |
| 19.02.26 | Nestlé Equal Weight | Barclays Capital | |
| 19.02.26 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 19.02.26 | Rio Tinto Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Nestlé Hold | Jefferies & Company Inc. | |
| 19.02.26 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 19.02.26 | T-Mobile US Market-Perform | Bernstein Research | |
| 19.02.26 | Airbus Buy | Goldman Sachs Group Inc. | |
| 19.02.26 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 19.02.26 | Linde Outperform | Bernstein Research | |
| 19.02.26 | AIR France-KLM Overweight | JP Morgan Chase & Co. | |
| 19.02.26 | Rio Tinto Overweight | Barclays Capital | |
| 19.02.26 | Renault Hold | Jefferies & Company Inc. | |
| 19.02.26 | Südzucker Hold | Warburg Research | |
| 19.02.26 | Knorr-Bremse Buy | Jefferies & Company Inc. | |
| 19.02.26 | Renault Outperform | Bernstein Research | |
| 19.02.26 | KRONES Buy | Jefferies & Company Inc. | |
| 19.02.26 | Richemont Outperform | Bernstein Research |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.